<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38203745</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">574</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25010574</ELocationID><Abstract><AbstractText>Post-viral fatigue syndrome (PVFS) encompasses a wide range of complex neuroimmune disorders of unknown causes characterised by disabling post-exertional fatigue, myalgia and joint pain, cognitive impairments, unrefreshing sleep, autonomic dysfunction, and neuropsychiatric symptoms. It includes myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS); fibromyalgia (FM); and more recently post-COVID-19 condition (long COVID). To date, there are no definitive clinical case criteria and no FDA-approved pharmacological therapies for PVFS. Given the current lack of effective treatments, there is a need to develop novel therapeutic strategies for these disorders. Mitochondria, the cellular organelles responsible for tissue energy production, have recently garnered attention in research into PVFS due to their crucial role in cellular bioenergetic metabolism in these conditions. The accumulating literature has identified a link between mitochondrial dysfunction and low-grade systemic inflammation in ME/CFS, FM, and long COVID. To address this issue, this article aims to critically review the evidence relating to mitochondrial dysfunction in the pathogenesis of these disorders; in particular, it aims to evaluate the effectiveness of coenzyme Q10 supplementation on chronic fatigue and pain symptoms as a novel therapeutic strategy for the treatment of PVFS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mantle</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pharma Nord (UK) Ltd., Morpeth, Northumberland NE61 2DB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hargreaves</LastName><ForeName>Iain Parry</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domingo</LastName><ForeName>Joan Carles</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-6356-0836</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro-Marrero</LastName><ForeName>Jesus</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2481-3052</Identifier><AffiliationInfo><Affiliation>Research Unit in ME/CFS and Long COVID, Rheumatology Division, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EJ27X76M46</RegistryNumber><NameOfSubstance UI="C024989">coenzyme Q10</NameOfSubstance></Chemical><Chemical><RegistryNumber>1339-63-5</RegistryNumber><NameOfSubstance UI="D014451">Ubiquinone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005356" MajorTopicYN="Y">Fibromyalgia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028361" MajorTopicYN="Y">Mitochondrial Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014451" MajorTopicYN="N">Ubiquinone</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">coenzyme Q10</Keyword><Keyword MajorTopicYN="N">fibromyalgia</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">post-viral fatigue syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. Dr Mantle is medical adviser to Pharma Nord (UK) Ltd.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>7</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38203745</ArticleId><ArticleId IdType="pmc">PMC10779395</ArticleId><ArticleId IdType="doi">10.3390/ijms25010574</ArticleId><ArticleId IdType="pii">ijms25010574</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Komaroff A.L., Lipkin W.I. ME/CFS and Long COVID share similar symptoms and biological abnormalities: Road map to the literature. Front. Med. 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L. Chronic &#x201c;post-infectious&#x201d; fatigue syndrome. Trans. Am. Acad. Insur. Med. 1993;76:82&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">8337774</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Ther. Adv. Infect. Dis. 2021;8:20499361211009385. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahroum N., Shoenfeld Y. Autoimmune Autonomic Dysfunction Syndromes: Potential Involvement and Pathophysiology Related to Complex Regional Pain Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Silicone Breast Implant-Related Symptoms and Post-COVID Syndrome. Pathophysiology. 2022;29:414&#x2013;425. doi: 10.3390/pathophysiology29030033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology29030033</ArticleId><ArticleId IdType="pmc">PMC9396987</ArticleId><ArticleId IdType="pubmed">35997389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton W.T., Gallagher A.M., Thomas J.M., White P.D. The prognosis of different fatigue diagnostic labels: A longitudinal survey. Fam. Pract. 2005;22:383&#x2013;388. doi: 10.1093/fampra/cmi021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmi021</ArticleId><ArticleId IdType="pubmed">15805126</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan P.O., Behan W.M., Gow J.W., Cavanagh H., Gillespie S. Enteroviruses and postviral fatigue syndrome. Ciba Found. Symp. 1993;173:146&#x2013;154. doi: 10.1002/9780470514382.ch9. discussion 154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470514382.ch9</ArticleId><ArticleId IdType="pubmed">8387908</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga I., Aranburu L., Gargiulo P.A., Gomez Esteban J.C., Lafuente J.V. Clinical Heterogeneity in ME/CFS. A Way to Understand Long-COVID19 Fatigue. Front. Psychiatry. 2021;12:735784. doi: 10.3389/fpsyt.2021.735784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.735784</ArticleId><ArticleId IdType="pmc">PMC8542754</ArticleId><ArticleId IdType="pubmed">34707521</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Saez-Francas N., Santillo D., Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: All roads lead to Rome. Br. J. Pharmacol. 2017;174:345&#x2013;369. doi: 10.1111/bph.13702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13702</ArticleId><ArticleId IdType="pmc">PMC5301046</ArticleId><ArticleId IdType="pubmed">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S., Eaton-Fitch N. Understanding myalgic encephalomyelitis. Science. 2022;377:1150&#x2013;1151. doi: 10.1126/science.abo1261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo1261</ArticleId><ArticleId IdType="pubmed">36074854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazurkiewicz I., Chatys-Bogacka Z., Slowik J., Klich-Raczka A., Fedyk-Lukasik M., Slowik A., Wnuk M., Drabik L. Fatigue after COVID-19 in non-hospitalized patients according to sex. Brain Behav. 2023;13:e2849. doi: 10.1002/brb3.2849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2849</ArticleId><ArticleId IdType="pmc">PMC9927850</ArticleId><ArticleId IdType="pubmed">36620918</ArticleId></ArticleIdList></Reference><Reference><Citation>Faro M., Saez-Francas N., Castro-Marrero J., Aliste L., Fernandez de Sevilla T., Alegre J. Gender differences in chronic fatigue syndrome. Reumatol. Clin. 2016;12:72&#x2013;77. doi: 10.1016/j.reuma.2015.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2015.05.007</ArticleId><ArticleId IdType="pubmed">26190206</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Quach T.C., Tiwari A., Bonilla A.E., Miglis M., Yang P.C., Eggert L.E., Sharifi H., Horomanski A., Subramanian A., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. Front. Neurol. 2023;14:1090747. doi: 10.3389/fneur.2023.1090747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese C., Kirchner E., Calabrese L.H. Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications. Best. Pract. Res. Clin. Rheumatol. 2022;36:101794. doi: 10.1016/j.berh.2022.101794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2022.101794</ArticleId><ArticleId IdType="pmc">PMC9641578</ArticleId><ArticleId IdType="pubmed">36369208</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi M.B., Javanmard S.H. Post-COVID-19 Syndrome Mechanisms, Prevention and Management. Int. J. Prev. Med. 2023;14:59. doi: 10.4103/ijpvm.ijpvm_508_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijpvm.ijpvm_508_21</ArticleId><ArticleId IdType="pmc">PMC10284243</ArticleId><ArticleId IdType="pubmed">37351054</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Shetty A., Delanerolle G., Zeng Y., Zhang Y., Raymont V., Rathod S., Halabi S., Elliot K., Shi J.Q., et al. A systematic review and meta-analysis of long COVID symptoms. Syst. Rev. 2023;12:88. doi: 10.1186/s13643-023-02250-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslam A., Olivier T., Prasad V. The definition of long COVID used in interventional studies. Eur. J. Clin. Investig. 2023;53:e13989. doi: 10.1111/eci.13989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13989</ArticleId><ArticleId IdType="pubmed">36964995</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi M., Al-Najjar Y., Sharma O., Kamal I., Javed A., Gohil H.S., Paul P., Al-Khalifa A.M., Laws S., Zakaria D. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: A systematic review. BMC Infect. Dis. 2023;23:432. doi: 10.1186/s12879-023-08328-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08328-3</ArticleId><ArticleId IdType="pmc">PMC10294418</ArticleId><ArticleId IdType="pubmed">37365490</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., Luscher T.F., Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110:914&#x2013;921. doi: 10.1111/apa.15673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate W.P., Walker M.O.M., Peppercorn K., Blair A.L.H., Edgar C.D. Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID. Int. J. Mol. Sci. 2023;24:5124. doi: 10.3390/ijms24065124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065124</ArticleId><ArticleId IdType="pmc">PMC10048882</ArticleId><ArticleId IdType="pubmed">36982194</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Barhorst E.E., Boruch A.E., Cook D.B., Lindheimer J.B. Pain-Related Post-Exertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia: A Systematic Review and Three-Level Meta-Analysis. Pain. Med. 2022;23:1144&#x2013;1157. doi: 10.1093/pm/pnab308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnab308</ArticleId><ArticleId IdType="pubmed">34668532</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinali D.P., Brown G.M., Pandi-Perumal S.R. Possible Application of Melatonin in Long COVID. Biomolecules. 2022;12:1646. doi: 10.3390/biom12111646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12111646</ArticleId><ArticleId IdType="pmc">PMC9687267</ArticleId><ArticleId IdType="pubmed">36358996</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter N.S., Jason L.A., Boulton A., Bothne N., Coleman B. Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J. Altern. Complement. Med. 2010;16:235&#x2013;249. doi: 10.1089/acm.2008.0376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2008.0376</ArticleId><ArticleId IdType="pubmed">20192908</ArticleId></ArticleIdList></Reference><Reference><Citation>Skilbeck L. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care&#x2014;A case study. Chronic Illn. 2022;18:691&#x2013;701. doi: 10.1177/17423953221113605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17423953221113605</ArticleId><ArticleId IdType="pubmed">35821571</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker M., Sawant H.B., Flannery T., Tarrant R., Shardha J., Bannister R., Ross D., Halpin S., Greenwood D.C., Sivan M. Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome. J. Med. Virol. 2023;95:e28373. doi: 10.1002/jmv.28373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28373</ArticleId><ArticleId IdType="pmc">PMC9878088</ArticleId><ArticleId IdType="pubmed">36461167</ArticleId></ArticleIdList></Reference><Reference><Citation>Annesley S.J., Fisher P.R. Mitochondria in Health and Disease. Cells. 2019;8:680. doi: 10.3390/cells8070680.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8070680</ArticleId><ArticleId IdType="pmc">PMC6678092</ArticleId><ArticleId IdType="pubmed">31284394</ArticleId></ArticleIdList></Reference><Reference><Citation>San-Millan I. The Key Role of Mitochondrial Function in Health and Disease. Antioxidants. 2023;12:782. doi: 10.3390/antiox12040782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12040782</ArticleId><ArticleId IdType="pmc">PMC10135185</ArticleId><ArticleId IdType="pubmed">37107158</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace D.C. A mitochondrial bioenergetic etiology of disease. J. Clin. Investig. 2013;123:1405&#x2013;1412. doi: 10.1172/JCI61398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI61398</ArticleId><ArticleId IdType="pmc">PMC3614529</ArticleId><ArticleId IdType="pubmed">23543062</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front. Med. 2020;7:606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden S., Maksoud R., Eaton-Fitch N., Cabanas H., Staines D., Marshall-Gradisnik S. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease. J. Transl. Med. 2020;18:290. doi: 10.1186/s12967-020-02452-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02452-3</ArticleId><ArticleId IdType="pmc">PMC7392668</ArticleId><ArticleId IdType="pubmed">32727475</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S., Booth N.E., McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2009;2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680051</ArticleId><ArticleId IdType="pubmed">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Cordero M.D., Saez-Francas N., Jimenez-Gutierrez C., Aguilar-Montilla F.J., Aliste L., Alegre-Martin J. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid. Redox Signal. 2013;19:1855&#x2013;1860. doi: 10.1089/ars.2013.5346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5346</ArticleId><ArticleId IdType="pubmed">23600892</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Brown A.E., Newton J.L., Elson J.L. Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types. PeerJ. 2019;7:e6500. doi: 10.7717/peerj.6500.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.6500</ArticleId><ArticleId IdType="pmc">PMC6398432</ArticleId><ArticleId IdType="pubmed">30847260</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.L., Bore P.J., Radda G.K., Styles P., Taylor D.J. Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. A 31P nuclear magnetic resonance study. Lancet. 1984;1:1367&#x2013;1369. doi: 10.1016/S0140-6736(84)91871-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(84)91871-3</ArticleId><ArticleId IdType="pubmed">6145831</ArticleId></ArticleIdList></Reference><Reference><Citation>Plioplys A.V., Plioplys S. Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome. Neuropsychobiology. 1995;32:175&#x2013;181. doi: 10.1159/000119233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000119233</ArticleId><ArticleId IdType="pubmed">8587699</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintos-Pascual I., Moreno-Torres V., Ibanez-Estellez F., Corrales-Rodriguez P., Trevino A., Corpas M., Corral O., Soriano V., de Mendoza C. Is SARS-CoV-2 the only cause of long-COVID? AIDS Rev. 2022;24:183&#x2013;196. doi: 10.24875/AIDSRev.22000025.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/AIDSRev.22000025</ArticleId><ArticleId IdType="pubmed">36427058</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapaliya K., Marshall-Gradisnik S., Barth M., Eaton-Fitch N., Barnden L. Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients. Front. Neurosci. 2023;17:1125208. doi: 10.3389/fnins.2023.1125208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1125208</ArticleId><ArticleId IdType="pmc">PMC10017877</ArticleId><ArticleId IdType="pubmed">36937672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., Brown A., Strassheim V., Elson J.L., Newton J., Manning P. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE. 2017;12:e0186802. doi: 10.1371/journal.pone.0186802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType="pmc">PMC5655451</ArticleId><ArticleId IdType="pubmed">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Smits B., van den Heuvel L., Knoop H., Kusters B., Janssen A., Borm G., Bleijenberg G., Rodenburg R., van Engelen B. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion. 2011;11:735&#x2013;738. doi: 10.1016/j.mito.2011.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2011.05.005</ArticleId><ArticleId IdType="pubmed">21664495</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordero M.D., de Miguel M., Carmona-Lopez I., Bonal P., Campa F., Moreno-Fernandez A.M. Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol. Lett. 2010;31:169&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">20424583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J.L., Navis G.J., Gordijn S.J., Bolling M.C., Dijkstra G., Voors A.A., Osterhaus A.D., et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) J. Pathol. 2020;251:228&#x2013;248. doi: 10.1002/path.5471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5471</ArticleId><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K.K., Chaubey G., Chen J.Y., Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am. J. Physiol. Cell Physiol. 2020;319:C258&#x2013;C267. doi: 10.1152/ajpcell.00224.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiku V., Tan M.W., Dikic I. Mitochondrial Functions in Infection and Immunity. Trends Cell Biol. 2020;30:263&#x2013;275. doi: 10.1016/j.tcb.2020.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2020.01.006</ArticleId><ArticleId IdType="pmc">PMC7126537</ArticleId><ArticleId IdType="pubmed">32200805</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D., Klann K., Koch B., Widera M., Krause D., Ciesek S., Cinatl J., Munch C. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583:469&#x2013;472. doi: 10.1038/s41586-020-2332-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2332-7</ArticleId><ArticleId IdType="pubmed">32408336</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabanas H., Muraki K., Eaton N., Balinas C., Staines D., Marshall-Gradisnik S. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Mol. Med. 2018;24:44. doi: 10.1186/s10020-018-0046-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-018-0046-1</ArticleId><ArticleId IdType="pmc">PMC6092868</ArticleId><ArticleId IdType="pubmed">30134818</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabanas H., Muraki K., Balinas C., Eaton-Fitch N., Staines D., Marshall-Gradisnik S. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients. Mol. Med. 2019;25:14. doi: 10.1186/s10020-019-0083-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-019-0083-4</ArticleId><ArticleId IdType="pmc">PMC6480905</ArticleId><ArticleId IdType="pubmed">31014226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabanas H., Muraki K., Eaton-Fitch N., Staines D.R., Marshall-Gradisnik S. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment. Front. Immunol. 2021;12:687806. doi: 10.3389/fimmu.2021.687806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.687806</ArticleId><ArticleId IdType="pmc">PMC8313851</ArticleId><ArticleId IdType="pubmed">34326841</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabanas H., Muraki K., Staines D., Marshall-Gradisnik S. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Front. Immunol. 2019;10:2545. doi: 10.3389/fimmu.2019.02545.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02545</ArticleId><ArticleId IdType="pmc">PMC6834647</ArticleId><ArticleId IdType="pubmed">31736966</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D., Annesley S.J., Fisher P.R. Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Diagnostics. 2019;9:80. doi: 10.3390/diagnostics9030080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030080</ArticleId><ArticleId IdType="pmc">PMC6787592</ArticleId><ArticleId IdType="pubmed">31330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Berk M., Galecki P., Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs) Mol. Neurobiol. 2014;49:741&#x2013;756. doi: 10.1007/s12035-013-8553-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8553-0</ArticleId><ArticleId IdType="pubmed">24068616</ArticleId></ArticleIdList></Reference><Reference><Citation>van Tilburg M.A.L., Parisien M., Boles R.G., Drury G.L., Smith-Voudouris J., Verma V., Khoury S., Chabot-Dore A.J., Nackley A.G., Smith S.B., et al. A genetic polymorphism that is associated with mitochondrial energy metabolism increases risk of fibromyalgia. Pain. 2020;161:2860&#x2013;2871. doi: 10.1097/j.pain.0000000000001996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001996</ArticleId><ArticleId IdType="pmc">PMC7669626</ArticleId><ArticleId IdType="pubmed">32658146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovrom E.A., Mostert K.A., Khakhkhar S., McKee D.P., Yang P., Her Y.F. A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia. Biomedicines. 2023;11:1119. doi: 10.3390/biomedicines11041119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11041119</ArticleId><ArticleId IdType="pmc">PMC10135661</ArticleId><ArticleId IdType="pubmed">37189737</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Taylor K., Kozubek J., Sardell J., Gardner S. Genetic risk factors for ME/CFS identified using combinatorial analysis. J. Transl. Med. 2022;20:598. doi: 10.1186/s12967-022-03815-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03815-8</ArticleId><ArticleId IdType="pmc">PMC9749644</ArticleId><ArticleId IdType="pubmed">36517845</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi L., La Motta C. The Use of the Coenzyme Q10 as a Food Supplement in the Management of Fibromyalgia: A Critical Review. Antioxidants. 2022;11:1969. doi: 10.3390/antiox11101969.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11101969</ArticleId><ArticleId IdType="pmc">PMC9598746</ArticleId><ArticleId IdType="pubmed">36290691</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Araque A., Verde Z., Torres-Ortega C., Sainz-Gil M., Velasco-Gonzalez V., Gonzalez-Bernal J.J., Mielgo-Ayuso J. Effects of Antioxidants on Pain Perception in Patients with Fibromyalgia&#x2014;A Systematic Review. J. Clin. Med. 2022;11:2462. doi: 10.3390/jcm11092462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11092462</ArticleId><ArticleId IdType="pmc">PMC9099826</ArticleId><ArticleId IdType="pubmed">35566585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hargreaves I.P., Mantle D. Targeted Treatment of Age-Related Fibromyalgia with Supplemental Coenzyme Q10. Adv. Exp. Med. Biol. 2021;1286:77&#x2013;85. doi: 10.1007/978-3-030-55035-6_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-55035-6_5</ArticleId><ArticleId IdType="pubmed">33725346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry E., Marley J., McVeigh J.G., McSorley E., Allsopp P., Kerr D. Dietary Interventions in the Management of Fibromyalgia: A Systematic Review and Best-Evidence Synthesis. Nutrients. 2020;12:2664. doi: 10.3390/nu12092664.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12092664</ArticleId><ArticleId IdType="pmc">PMC7551150</ArticleId><ArticleId IdType="pubmed">32878326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrabani S., Askari G., Miraghajani M., Tavakoly R., Arab A. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies. Complement. Ther. Med. 2019;43:181&#x2013;187. doi: 10.1016/j.ctim.2019.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctim.2019.01.022</ArticleId><ArticleId IdType="pubmed">30935528</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Cordero M.D., Segundo M.J., Saez-Francas N., Calvo N., Roman-Malo L., Aliste L., Fernandez de Sevilla T., Alegre J. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid. Redox Signal. 2015;22:679&#x2013;685. doi: 10.1089/ars.2014.6181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2014.6181</ArticleId><ArticleId IdType="pmc">PMC4346380</ArticleId><ArticleId IdType="pubmed">25386668</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Saez-Francas N., Segundo M.J., Calvo N., Faro M., Aliste L., Fernandez de Sevilla T., Alegre J. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome: A randomized, controlled, double-blind trial. Clin. Nutr. 2016;35:826&#x2013;834. doi: 10.1016/j.clnu.2015.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2015.07.010</ArticleId><ArticleId IdType="pubmed">26212172</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Segundo M.J., Lacasa M., Martinez-Martinez A., Sentanes R.S., Alegre-Martin J. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021;13:2658. doi: 10.3390/nu13082658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13082658</ArticleId><ArticleId IdType="pmc">PMC8399248</ArticleId><ArticleId IdType="pubmed">34444817</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Domingo J.C., Cordobilla B., Ferrer R., Giralt M., Sanmartin-Sentanes R., Alegre-Martin J. Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Antioxid. Redox Signal. 2022;36:729&#x2013;739. doi: 10.1089/ars.2022.0018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2022.0018</ArticleId><ArticleId IdType="pmc">PMC9057907</ArticleId><ArticleId IdType="pubmed">35229657</ArticleId></ArticleIdList></Reference><Reference><Citation>Banoth B., Cassel S.L. Mitochondria in innate immune signaling. Transl. Res. 2018;202:52&#x2013;68. doi: 10.1016/j.trsl.2018.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2018.07.014</ArticleId><ArticleId IdType="pmc">PMC6218307</ArticleId><ArticleId IdType="pubmed">30165038</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez C., Horner S.M. MAVS Coordination of Antiviral Innate Immunity. J. Virol. 2015;89:6974&#x2013;6977. doi: 10.1128/JVI.01918-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01918-14</ArticleId><ArticleId IdType="pmc">PMC4473567</ArticleId><ArticleId IdType="pubmed">25948741</ArticleId></ArticleIdList></Reference><Reference><Citation>Roingeard P., Eymieux S., Burlaud-Gaillard J., Hourioux C., Patient R., Blanchard E. The double-membrane vesicle (DMV): A virus-induced organelle dedicated to the replication of SARS-CoV-2 and other positive-sense single-stranded RNA viruses. Cell. Mol. Life Sci. 2022;79:425. doi: 10.1007/s00018-022-04469-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04469-x</ArticleId><ArticleId IdType="pmc">PMC9287701</ArticleId><ArticleId IdType="pubmed">35841484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G., Melia C.E., Snijder E.J., Barcena M. Double-Membrane Vesicles as Platforms for Viral Replication. Trends Microbiol. 2020;28:1022&#x2013;1033. doi: 10.1016/j.tim.2020.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.05.009</ArticleId><ArticleId IdType="pmc">PMC7289118</ArticleId><ArticleId IdType="pubmed">32536523</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S.P., Amar S., Gehlot P., Patra S.K., Kanwar N., Kanwal A. Mitochondrial Modulations, Autophagy Pathways Shifts in Viral Infections: Consequences of COVID-19. Int. J. Mol. Sci. 2021;22:8180. doi: 10.3390/ijms22158180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158180</ArticleId><ArticleId IdType="pmc">PMC8347486</ArticleId><ArticleId IdType="pubmed">34360945</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Hou P., Ma W., Wang X., Wang H., Yu Z., Chang H., Wang T., Jin S., Wang X., et al. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Cell. Mol. Immunol. 2022;19:67&#x2013;78. doi: 10.1038/s41423-021-00807-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00807-4</ArticleId><ArticleId IdType="pmc">PMC8628139</ArticleId><ArticleId IdType="pubmed">34845370</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta S., Das N., Mukherjee P. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses. Front. Microbiol. 2020;11:1990. doi: 10.3389/fmicb.2020.01990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01990</ArticleId><ArticleId IdType="pmc">PMC7487669</ArticleId><ArticleId IdType="pubmed">32983015</ArticleId></ArticleIdList></Reference><Reference><Citation>Gvozdjakova A., Kucharska J., Sumbalova Z., Rausova Z., Chladekova A., Komlosi M., Szamosova M., Mojto V. The importance of coenzyme Q10 and its ratio to cholesterol in the progress of chronic kidney diseases linked to non-communicable diseases. Bratisl. Med. J. 2020;121:693&#x2013;699. doi: 10.4149/BLL_2020_113.</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/BLL_2020_113</ArticleId><ArticleId IdType="pubmed">32955899</ArticleId></ArticleIdList></Reference><Reference><Citation>Barletta M.A., Marino G., Spagnolo B., Bianchi F.P., Falappone P.C.F., Spagnolo L., Gatti P. Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome. Clin. Exp. Med. 2023;23:667&#x2013;678. doi: 10.1007/s10238-022-00871-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-022-00871-8</ArticleId><ArticleId IdType="pmc">PMC9395797</ArticleId><ArticleId IdType="pubmed">35994177</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen K.S., Mogensen T.H., Agergaard J., Schiottz-Christensen B., Ostergaard L., Vibholm L.K., Leth S. High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: A randomized, phase 2, crossover trial. Lancet Reg. Health Eur. 2023;24:100539. doi: 10.1016/j.lanepe.2022.100539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100539</ArticleId><ArticleId IdType="pmc">PMC9627534</ArticleId><ArticleId IdType="pubmed">36337437</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordero M.D., Alcocer-Gomez E., de Miguel M., Culic O., Carrion A.M., Alvarez-Suarez J.M., Bullon P., Battino M., Fernandez-Rodriguez A., Sanchez-Alcazar J.A. Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? Antioxid. Redox Signal. 2013;19:1356&#x2013;1361. doi: 10.1089/ars.2013.5260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5260</ArticleId><ArticleId IdType="pubmed">23458405</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcocer-Gomez E., Sanchez-Alcazar J.A., Cordero M.D. Coenzyme q10 regulates serotonin levels and depressive symptoms in fibromyalgia patients: Results of a small clinical trial. J. Clin. Psychopharmacol. 2014;34:277&#x2013;278. doi: 10.1097/JCP.0000000000000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0000000000000097</ArticleId><ArticleId IdType="pubmed">24525646</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcocer-Gomez E., Culic O., Navarro-Pando J.M., Sanchez-Alcazar J.A., Bullon P. Effect of Coenzyme Q(10) on Psychopathological Symptoms in Fibromyalgia Patients. CNS Neurosci. Ther. 2017;23:188&#x2013;189. doi: 10.1111/cns.12668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12668</ArticleId><ArticleId IdType="pmc">PMC6492687</ArticleId><ArticleId IdType="pubmed">28052569</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordero M.D., Cano-Garcia F.J., Alcocer-Gomez E., De Miguel M., Sanchez-Alcazar J.A. Oxidative stress correlates with headache symptoms in fibromyalgia: Coenzyme Q10 effect on clinical improvement. PLoS ONE. 2012;7:e35677. doi: 10.1371/journal.pone.0035677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035677</ArticleId><ArticleId IdType="pmc">PMC3330812</ArticleId><ArticleId IdType="pubmed">22532869</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pierro F., Rossi A., Consensi A., Giacomelli C., Bazzichi L. Role for a water-soluble form of CoQ10 in female subjects affected by fibromyalgia. A preliminary study. Clin. Exp. Rheumatol. 2017;35((Suppl. S105)):20&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">27974102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaddiruk P., Apaijai N., Paiboonworachat S., Kaewchur T., Kasitanon N., Jaiwongkam T., Kerdphoo S., Chattipakorn N., Chattipakorn S.C. Coenzyme Q10 supplementation alleviates pain in pregabalin-treated fibromyalgia patients via reducing brain activity and mitochondrial dysfunction. Free Radic. Res. 2019;53:901&#x2013;909. doi: 10.1080/10715762.2019.1645955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715762.2019.1645955</ArticleId><ArticleId IdType="pubmed">31387429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lister R.E. An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome. J. Int. Med. Res. 2002;30:195&#x2013;199. doi: 10.1177/147323000203000213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/147323000203000213</ArticleId><ArticleId IdType="pubmed">12025528</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweiger V., Secchettin E., Castellani C., Martini A., Mazzocchi E., Picelli A., Polati E., Donadello K., Valenti M.T., Dalle Carbonare L. Comparison between Acupuncture and Nutraceutical Treatment with Migratens((R)) in Patients with Fibromyalgia Syndrome: A Prospective Randomized Clinical Trial. Nutrients. 2020;12:821. doi: 10.3390/nu12030821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12030821</ArticleId><ArticleId IdType="pmc">PMC7146219</ArticleId><ArticleId IdType="pubmed">32204554</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel A., Schaffer A.A., Cicurel A., Feldhamer I., Tal A., Cheng K., Sinha S., Schiff E., Lavie G., Ruppin E. Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population. medRxiv. 2021 doi: 10.1101/2020.10.13.20211953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.13.20211953</ArticleId><ArticleId IdType="pmc">PMC8321549</ArticleId><ArticleId IdType="pubmed">34313216</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S., Nojima J., Kajimoto O., Yamaguti K., Nakatomi Y., Kuratsune H., Watanabe Y. Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome. Biofactors. 2016;42:431&#x2013;440. doi: 10.1002/biof.1293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1293</ArticleId><ArticleId IdType="pubmed">27125909</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordero M.D., Diaz-Parrado E., Carrion A.M., Alfonsi S., Sanchez-Alcazar J.A., Bullon P., Battino M., de Miguel M. Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid. Redox Signal. 2013;18:800&#x2013;807. doi: 10.1089/ars.2012.4892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.4892</ArticleId><ArticleId IdType="pmc">PMC3555092</ArticleId><ArticleId IdType="pubmed">22938055</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamae T., Seki M., Naga T., Uchino S., Asazuma H., Yoshida T., Iizuka Y., Kikuchi M., Imagawa T., Natsumeda Y., et al. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: Amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep. 2013;18:12&#x2013;19. doi: 10.1179/1351000212Y.0000000036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1351000212Y.0000000036</ArticleId><ArticleId IdType="pmc">PMC6837523</ArticleId><ArticleId IdType="pubmed">23394493</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno Fernandez-Ayala D.J., Navas P., Lopez-Lluch G. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp. Gerontol. 2020;142:111147. doi: 10.1016/j.exger.2020.111147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2020.111147</ArticleId><ArticleId IdType="pmc">PMC7648491</ArticleId><ArticleId IdType="pubmed">33171276</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso F., Rossi M., Pedersen J.Z., Incerpi S. Computational studies reveal mechanism by which quinone derivatives can inhibit SARS-CoV-2. Study of embelin and two therapeutic compounds of interest, methyl prednisolone and dexamethasone. J. Infect. Public. Health. 2020;13:1868&#x2013;1877. doi: 10.1016/j.jiph.2020.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.09.015</ArticleId><ArticleId IdType="pmc">PMC7556809</ArticleId><ArticleId IdType="pubmed">33109497</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.I., Saad J.M., Han Y., Alahdab F., Malahfji M., Nabi F., Mahmarian J.J., Cooke J.P., Zoghbi W.A., Al-Mallah M.H. Coronary Microvascular Health in Patients With Prior COVID-19 Infection. JACC Cardiovasc. Imaging. 2022;15:2153&#x2013;2155. doi: 10.1016/j.jcmg.2022.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2022.07.006</ArticleId><ArticleId IdType="pmc">PMC9385193</ArticleId><ArticleId IdType="pubmed">36481086</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A.J., Sykes R., McIntosh A., Kamdar A., Bagot C., Bayes H.K., Blyth K.G., Briscoe M., Bulluck H., Carrick D., et al. A multisystem, cardio-renal investigation of post-COVID-19 illness. Nat. Med. 2022;28:1303&#x2013;1313. doi: 10.1038/s41591-022-01837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01837-9</ArticleId><ArticleId IdType="pmc">PMC9205780</ArticleId><ArticleId IdType="pubmed">35606551</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle D., Heaton R.A., Hargreaves I.P. Coenzyme Q10 and Immune Function: An Overview. Antioxidants. 2021;10:759. doi: 10.3390/antiox10050759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10050759</ArticleId><ArticleId IdType="pmc">PMC8150987</ArticleId><ArticleId IdType="pubmed">34064686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hargreaves I.R., Mantle D. COVID-19, Coenzyme Q10 and Selenium. Adv. Exp. Med. Biol. 2021;1327:161&#x2013;168. doi: 10.1007/978-3-030-71697-4_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-71697-4_13</ArticleId><ArticleId IdType="pubmed">34279837</ArticleId></ArticleIdList></Reference><Reference><Citation>Alehagen U., Johansson P., Bjornstedt M., Rosen A., Dahlstrom U. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: A 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. Int. J. Cardiol. 2013;167:1860&#x2013;1866. doi: 10.1016/j.ijcard.2012.04.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.04.156</ArticleId><ArticleId IdType="pubmed">22626835</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortensen S.A., Rosenfeldt F., Kumar A., Dolliner P., Filipiak K.J., Pella D., Alehagen U., Steurer G., Littarru G.P., Investigators Q.S.S. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: Results from Q-SYMBIO: A randomized double-blind trial. JACC Heart Fail. 2014;2:641&#x2013;649. doi: 10.1016/j.jchf.2014.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2014.06.008</ArticleId><ArticleId IdType="pubmed">25282031</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L., Authier F.J., Scheibenbogen C., Lorusso L., Helland I.B., Martin J.A., Sirbu C.A., Mengshoel A.M., Polo O., Behrends U., et al. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe. Medicina. 2021;57:510. doi: 10.3390/medicina57050510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050510</ArticleId><ArticleId IdType="pmc">PMC8161074</ArticleId><ArticleId IdType="pubmed">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Todic M. Dossier for marketing authorization in the European Union. Bosn. J. Basic Med. Sci. 2003;3:56&#x2013;60. doi: 10.17305/bjbms.2003.3572.</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bjbms.2003.3572</ArticleId><ArticleId IdType="pubmed">16209669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardella M., Belcher G., Lungu C., Ignoni T., Camisa M., Stenver D.I., Porcelli P., D&#x2019;Antuono M., Castiglione N.G., Adams A., et al. Monitoring the manufacturing and quality of medicines: A fundamental task of pharmacovigilance. Ther. Adv. Drug Saf. 2021;12:20420986211038436. doi: 10.1177/20420986211038436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20420986211038436</ArticleId><ArticleId IdType="pmc">PMC8361554</ArticleId><ArticleId IdType="pubmed">34394910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kressmann S., Muller W.E., Blume H.H. Pharmaceutical quality of different Ginkgo biloba brands. J. Pharm. Pharmacol. 2002;54:661&#x2013;669. doi: 10.1211/0022357021778970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1211/0022357021778970</ArticleId><ArticleId IdType="pubmed">12005361</ArticleId></ArticleIdList></Reference><Reference><Citation>Czigle S., Toth J., Jedlinszki N., Haznagy-Radnai E., Csupor D., Tekelova D. Ginkgo biloba Food Supplements on the European Market&#x2014;Adulteration Patterns Revealed by Quality Control of Selected Samples. Planta Med. 2018;84:475&#x2013;482. doi: 10.1055/a-0581-5203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0581-5203</ArticleId><ArticleId IdType="pubmed">29506293</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkowiak A., Wnuk K., Cyrankiewicz M., Kupcewicz B. Discrimination of Adulterated Ginkgo Biloba Products Based on 2T2D Correlation Spectroscopy in UV-Vis Range. Molecules. 2022;27:433. doi: 10.3390/molecules27020433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27020433</ArticleId><ArticleId IdType="pmc">PMC8777600</ArticleId><ArticleId IdType="pubmed">35056747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle D., Millichap L., Castro-Marrero J., Hargreaves I.P. Primary Coenzyme Q10 Deficiency: An Update. Antioxidants. 2023;12:1652. doi: 10.3390/antiox12081652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12081652</ArticleId><ArticleId IdType="pmc">PMC10451954</ArticleId><ArticleId IdType="pubmed">37627647</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle D., Dybring A. Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism. Antioxidants. 2020;9:386. doi: 10.3390/antiox9050386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9050386</ArticleId><ArticleId IdType="pmc">PMC7278738</ArticleId><ArticleId IdType="pubmed">32380795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Lluch G., Del Pozo-Cruz J., Sanchez-Cuesta A., Cortes-Rodriguez A.B., Navas P. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition. 2019;57:133&#x2013;140. doi: 10.1016/j.nut.2018.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2018.05.020</ArticleId><ArticleId IdType="pubmed">30153575</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle D., Lopez-Lluch G., Hargreaves I.P. Coenzyme Q10 Metabolism: A Review of Unresolved Issues. Int. J. Mol. Sci. 2023;24:2585. doi: 10.3390/ijms24032585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24032585</ArticleId><ArticleId IdType="pmc">PMC9916783</ArticleId><ArticleId IdType="pubmed">36768907</ArticleId></ArticleIdList></Reference><Reference><Citation>Crane F.L. Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 2001;20:591&#x2013;598. doi: 10.1080/07315724.2001.10719063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2001.10719063</ArticleId><ArticleId IdType="pubmed">11771674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hargreaves I.P. Coenzyme Q10 as a therapy for mitochondrial disease. Int. J. Biochem. Cell Biol. 2014;49:105&#x2013;111. doi: 10.1016/j.biocel.2014.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2014.01.020</ArticleId><ArticleId IdType="pubmed">24495877</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos V.M. A Potential Role of Coenzyme Q10 Deficiency in Severe SARS-CoV-2 Infection. OBM Integr. Complement. Med. 2020;5:042. doi: 10.21926/obm.icm.2004042.</Citation><ArticleIdList><ArticleId IdType="doi">10.21926/obm.icm.2004042</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.H., Chang C.J., Hung P.H. Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder. Int. J. Mol. Sci. 2023;24:8034. doi: 10.3390/ijms24098034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098034</ArticleId><ArticleId IdType="pmc">PMC10179190</ArticleId><ArticleId IdType="pubmed">37175745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle D., Hargreaves I.P. Mitochondrial Dysfunction and Neurodegenerative Disorders: Role of Nutritional Supplementation. Int. J. Mol. Sci. 2022;23:12603. doi: 10.3390/ijms232012603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232012603</ArticleId><ArticleId IdType="pmc">PMC9604531</ArticleId><ArticleId IdType="pubmed">36293457</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>